AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,596 Increased By 136 (0.53%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)
Technology

'Zantac' may cause cancer, being pulled from shelves in USA but not in Pakistan

Food and Drug Administration in US had issued warning of drug containing carcinogen ingredients. Canada, Franc
Published October 2, 2019
  • Food and Drug Administration in US had issued warning of drug containing carcinogen ingredients.
  • Canada, France and other countries have already suspended selling of drug.

Pharmacy chains in the United States have suspended the sale of heartburn medication Zantac after the Food and Drug Administration (FDA) issued a warning that the drug contained potentially cancer-causing ingredients.

The pharmacy chains Walgreens, Rite Aid and CVS have announced that they are no longer selling Zantac and other ranitidine products. Rite Aid is in the process of removing Zantac and generic versions sold under the Rite Aid name from its shelves, a Rite Aid spokesman told New York Times.

CVS has already announced that it has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice. "Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time," the CVS said.

Since the alert by FDA, Canada, France and other countries have removed the drugs from pharmacy shelves. Bangladesh also issued a temporary ban on the import, production and sale of ranitidine.

Drap engages international bodies for further probe after medicine recall over cancer fears

Ranitidine is a medication that works to lower the acid created in the stomach. The drug is also prescribed to prevent ulcers of the stomach and intestines as well as gastroesophageal reflux disease.

Last month, the FDA issued a statement alerting patients and health care professionals of N-nitrosodimethylamine (NDMA) found in samples of ranitidine. "The U.S. FDA has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels," the statement said.

NDMA is classified as a probable human carcinogen which is a substance that could cause cancer on the basis of animal studies. It is known environmental contaminant and found in water and foods, including meats, dairy products and vegetables.

Copyright Business Recorder, 2019

Comments

Comments are closed.